PKI News and Press, PerkinElmer Inc. From 11/02/21

PerkinElmer, Inc. (PKI) Q3 2021 Earnings Conference Call November 02, 2021 5:00 PM ET Company Participants Stephen Willoughby - Vice President of Investor Relations Prahlad Singh - President and Chief Executive Officer James Mock - Senior Vice President and Chief Financial Officer Peter Wrigh...

PerkinElmer (NYSE:PKI): Q3 Non-GAAP EPS of $2.31 beats by $0.56; GAAP EPS of $1.11 misses by $0.16. Revenue of $1.17B (+21.4% Y/Y) beats by $120M. Shares +1.71%. Press Release For Q4, the company forecasts adjusted revenue of approximately $1.2B vs. consensus of $1.05B and adjusted earnings p...

Revenue of $1.17 billion; 21% reported growth; 12% organic growth GAAP EPS from continuing operations of $1.11; Adjusted EPS of $2.31 Initiates Fourth Quarter Guidance and Raises Full Year Revenue and Earnings Guidance PerkinElmer, Inc . (NYSE: PKI), ...

Report highlights stewardship and sustainability progress and solidifies new ESG commitments PerkinElmer, Inc. (NYSE: PKI), a global leader innovating for a healthier world, today released its 2021 Corporate Social Responsibility (CSR) Report, which summarizes the latest...

Enzo Biochem (NYSE:ENZ) has added ~6.1% in the pre-market after the company announced Hamid Erfanian as its new CEO effective Nov. 08. Mr. Erfanian will replace former CEO Elazar Rabbani, who will step down according to a previously announced succession plan. Dr. Rabbani will b...

Flagship product from Honeycomb Biotechnologies advances single-cell profiling by enabling scientists to capture, store and study fragile cell types PerkinElmer, Inc. (NYSE: PKI) and Honeycomb Biotechnologies, Inc. , announced today the commercial launch of the f...

A dashboard with metrics in healthcare industries. Value and quality scores, and their evolution since last month. Focus on IBB. A list of cheap stocks. For further details see: IBB: Healthcare Dashboard For October

PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will release its third quarter 2021 financial results after market close on Tuesday, November 2, 2021. The Company will host a conference call the same day ...

RT-PCR test detects and differentiates SARS-CoV-2, influenza A, influenza B and respiratory syncytial virus PerkinElmer, Inc. (NYSE: PKI) announced today that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for the PKamp™...

Assay enabling the measurement of IgG antibodies could yield future discoveries and insights on immune responses to SARS-CoV-2 EUROIMMUN , a PerkinElmer, Inc. company (NYSE: PKI), announced today that the U.S. Food and Drug Administration has provided Emergency Use A...